universal flu vaccine

Universal flu vaccine means big bucks for biotech firms

Illustration: Rebecca Zisser/Axios

Osivax, a French developer of a universal flu vaccine, raised €8 million in Series A funding led by Noshaq.

Why it matters: Developing a universal flu vaccine is fast becoming biotech's holy grail.

The pandemic potential

Images of green H1N1 virus, responsible for the deadly Spanish Flue outbreak in 1918
The H1N1 virus, responsible for the deadly Spanish Flu outbreak in 1918. Photo: BSIP/UIG Via Getty Images

Another global threat — one that is a repeated refrain amongst the White House, Centers for Disease Control, former national security advisers and even Bill Gates — is a pandemic.

Between the lines: Influenza is of particular concern for health officials, even though there are more contagious viruses — for example, measles — and more deadly ones, like Ebola.